Magnetic Resonance Cholangiopancreatography
MRCP
Description
"Magnetic Resonance Cholangiopancreatography" (MRCP) scan is a specialized type of MRI that provides detailed images of the bile ducts, pancreas, and gallbladder. Doctors often recommend it when symptoms like jaundice, abdominal pain, or suspected gallstones occur. This non-invasive scan uses magnetic fields rather than contrast dye or invasive procedures. MRCP helps detect blockages, inflammation, or tumors in the biliary system. The scan supports accurate diagnosis and helps guide the next steps in managing digestive and liver conditions.
Category
GI Tract Function
Procedure
Non-Invasive
Sample Type
No biological sample is needed for this test.
Units
Not Applicable
Procedure Category
Scan
Test Group
Imaging Scans Group
Test Group Description
Imaging Scans Group: This group includes a variety of diagnostic imaging techniques used to visualize internal structures and organs in the body. These techniques may include X-rays, CT scans, MRI scans, ultrasound, and nuclear medicine scans.
Optimal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Normal Range
For All Individuals:
Result: Negative: No abnormalities detected.
Results That Differ From The Norm (Direct and Indirect Causes)
Abnormal results may indicate:
Bile duct cysts (Abnormal sacs filled with fluid within the bile ducts)
Bile duct stones (Hardened deposits in the bile ducts)
Biliary obstruction (Blockage in the bile ducts)
Biliary stricture (Narrowing of the bile ducts)
Cholangiocarcinoma (Cancer of the bile ducts)
Cholecystitis (Inflammation of the ga...
Key Reasons For Testing
Biliary and Pancreatic Visualization: Provides detailed imaging for diagnosing biliary and pancreatic conditions like stones or tumors.
Diagnostic Tool for Biliary Obstruction: Identifies causes and differentiates between benign and malignant strictures.
Preoperative Planning: Guides surgical planning for hepatobiliary and pancreatic procedures.
Evaluation of Pancreatic Neoplasms: Diagnoses and stages pancreatic tumors for treatment planning.
Non-invasive Alternative to ERCP: Offers a safer diagnostic option for biliary and pancreatic diseases.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Baron RL, Stanley RJ, Lee JK, Koehler RE, Levitt RG. Magnetic resonance cholangiopancreatography: a new technique for noninvasive imaging of the bile and pancreatic ducts. Radiology. 1991;179(2):357-364.
[2] Soto JA, Barish MA, Yucel EK, Chuttani R, Ferrucci JT. Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology. 1996;110(2):589-597.
[3] Fulcher AS, Turner MA, Capps GW. MR cholangiopancreatography: spectrum of pancreatic duct abnormalities. AJR Am J Roentgenol. 1999;173(2):325-329.
[4] Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR cholangiopancreatography of bile and pancreatic ducts. Radiographics. 2000;20(1):29-41.
[5] Lomas DJ, Bearcroft PW. Magnetic resonance cholangiopancreatography: methods and clinical applications. Br J Radiol. 1999;72(857):921-934.
[6] Matos C, Metens T, Devière J, Nicaise N, Struyven J, Van Ypersele C. Magnetic resonance cholangiopancreatography in the detection of common bile duct stones: comparison of breath-hold and respiratory-triggered techniques. AJR Am J Roentgenol. 1996;167(4):1037-1045.
[7] Yoshimitsu K, Honda H, Aibe H, et al. MR cholangiopancreatography of normal and abnormal pancreaticobiliary ducts. Radiographics. 1997;17(4):897-906.
[8] Manfredi R, Brizzi E, Masselli G, et al. MR cholangiopancreatography: technique and clinical applications. Eur Radiol. 2008;18(12):2785-2797.
[9] Sherman S, Lehman GA. ERCP- and MRCP-related biliary strictures. Endoscopy. 2001;33(2):160-167.
[10] Fidler J, Paulson EK, Layfield LJ, et al. MR cholangiopancreatography: effect of intravenous secretin administration on pancreatic duct visualization and caliber. Radiology. 1996;198(3):705-711.
[11] Sahani DV, Kalva SP, Farrell RJ, Maher MM, Mueller PR. MR cholangiopancreatography and its evolving role in the imaging of pancreatic and biliary neoplasms. Oncologist. 2001;6(5):416-425.
[12] Hann LE, Deng FM, Bodian CA, Rose D, Bach AM. MR cholangiopancreatography: comparison with endoscopic retrograde cholangiopancreatography. Radiology. 1997;203(3):761-768.
[13] Gupta RT, Brady CM, Lotz J, Johnson CD. MR cholangiopancreatography with secretin stimulation: spectrum of findings. Radiographics. 2004;24(4):1087-1106.
[14] Bluemke DA, Sahani D, Amendola M, et al. MR cholangiopancreatography: update on technique and clinical applications. Magn Reson Imaging Clin N Am. 2001;9(1):105-118.
[15] Catalano OA, Singh AH, Uppot RN, Hahn PF, Ferrone CR, Sahani DV. Vascular and biliary variants in the liver: implications for liver surgery. Radiographics. 2008;28(2):359-378.
[16] Boraschi P, Donati F, Gigoni R, et al. Indications, potentialities and limitations of MR cholangiopancreatography in pediatric patients. Pediatr Radiol. 2006;36(2):124-131.
[17] Araki T, Watanabe H, Kita T, et al. Magnetic resonance cholangiopancreatography: from data acquisition to clinical evaluation. Magn Reson Med Sci. 2006;5(1):1-14.